The Importance of the Individual in PrEP Uptake: Multilevel Correlates of PrEP Uptake Among Adolescent Girls and Young Women in Tshwane, South Africa

被引:1
作者
Bonner, Courtney Peasant [1 ]
Minnis, Alexandra M. [2 ]
Ndirangu, Jacqueline W. [1 ]
Browne, Felicia A. [1 ]
Speizer, Ilene [3 ]
Nyblade, Laura [2 ]
Ahmed, Khatija [4 ,5 ]
Wechsberg, Wendee M. [1 ]
机构
[1] RTI Int, Subst Use Gender & Appl Res Program, 3040 East Cornwallis Rd, Res Triangle Pk, NC 27709 USA
[2] RTI Int, Womens Global Hlth Imperat, Res Triangle Pk, NC USA
[3] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA
[4] Setshaba Res Ctr, Soshanguve, South Africa
[5] Univ Pretoria, Fac Hlth Sci, Dept Med Microbil, Pretoria, South Africa
基金
美国国家卫生研究院;
关键词
Adolescent girls and young women; Sub-Saharan Africa; Multilevel factors; PrEP initiation; PrEP uptake; HIV prevention; DAPIVIRINE VAGINAL RING; PREEXPOSURE PROPHYLAXIS; ADHERENCE; HIV-1; PREVENTION;
D O I
10.1007/s10461-023-04126-9
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Adolescent girls and young women (AGYW) account for 25% of new HIV infections in South Africa. Pre-exposure prophylaxis (PrEP) is approved by the South African Government, but the factors that promote PrEP uptake among AGYW are not well understood. This study examines multilevel factors associated with PrEP uptake among AGYW in six clinic catchment areas in Tshwane (Pretoria), South Africa. After consent/assent, PrEP-eligible AGYW (n = 448) completed a questionnaire assessing factors at the individual, network/interpersonal, and community levels and were prescribed PrEP in study clinics, if interested. A multivariable model, adjusting for clustering, assessed factors associated with PrEP uptake over a 9-month period. At the individual level, multiple partners in the past 3 months (OR = 0.47), perceived risk of HIV (OR = 0.71), and PrEP-related shame (OR = 0.63) were correlated with lower odds of PrEP uptake (ps & LE; 0.05). The findings highlight modifiable factors that should be addressed to support PrEP uptake efforts.
引用
收藏
页码:4124 / 4130
页数:7
相关论文
共 34 条
  • [1] [Anonymous], 2022, S AFRICA APPROVES DA
  • [2] Sexual Relationship Types, Partner HIV Self-Testing, and Pre-Exposure Prophylaxis Among South African Adolescent Girls and Young Women: A Latent Class Analysis
    Atkins, Kaitlyn
    Rucinski, Katherine
    Mudavanhu, Mutsa
    Holmes, Leah
    Mutunga, Lillian
    Kaufman, Michelle R.
    Bassett, Jean
    Van Rie, Annelies
    Schwartz, Sheree R.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2021, 86 (04) : 413 - 421
  • [3] Balkus JE, 2016, JAIDS-J ACQ IMM DEF, V72, P333, DOI 10.1097/QAI.0000000000000974
  • [4] Modified social ecological model: a tool to guide the assessment of the risks and risk contexts of HIV epidemics
    Baral, Stefan
    Logie, Carmen H.
    Grosso, Ashley
    Wirtz, Andrea L.
    Beyrer, Chris
    [J]. BMC PUBLIC HEALTH, 2013, 13
  • [5] How Stigma Surrounding the Use of HIV Preexposure Prophylaxis Undermines Prevention and Pleasure: A Call to Destigmatize "Truvada Whores"
    Calabrese, Sarah K.
    Underhill, Kristen
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2015, 105 (10) : 1960 - 1964
  • [6] Celum C, 2021, J INT AIDS SOC, V24
  • [7] Celum CL, 2016, VANGUARD STUDY
  • [8] PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial
    Celum, Connie
    Hosek, Sybil
    Tsholwana, Mandisa
    Kassim, Sheetal
    Mukaka, Shorai
    Dye, Bonnie J.
    Pathak, Subash
    Mgodi, Nyaradzo
    Bekker, Linda-Gail
    Donnell, Deborah J.
    Wilson, Ethan
    Yuha, Krista
    Anderson, Peter L.
    Agyei, Yaw
    Noble, Heather
    Rose, Scott M.
    Baeten, Jared M.
    Fogel, Jessica M.
    Adeyeye, Adeola
    Wiesner, Lubbe
    Rooney, James
    Delany-Moretlwe, Sinead
    [J]. PLOS MEDICINE, 2021, 18 (06)
  • [9] Delany-Moretlwe S, HIV R4P VIRT
  • [10] Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial
    Delany-Moretlwe, Sinead
    Hughes, James P.
    Bock, Peter
    Ouma, Samuel Gurrion
    Hunidzarira, Portia
    Kalonji, Dishiki
    Kayange, Noel
    Makhema, Joseph
    Mandima, Patricia
    Mathew, Carrie
    Spooner, Elizabeth
    Mpendo, Juliet
    Mukwekwerere, Pamela
    Mgodi, Nyaradzo
    Ntege, Patricia Nahirya
    Nair, Gonasagrie
    Nakabiito, Clemensia
    Nuwagaba-Biribonwoha, Harriet
    Panchia, Ravindre
    Singh, Nishanta
    Siziba, Bekezela
    Farrior, Jennifer
    Rose, Scott
    Anderson, Peter L.
    Eshleman, Susan H.
    Marzinke, Mark A.
    Hendrix, Craig W.
    Beigel-Orme, Stephanie
    Hosek, Sybil
    Tolley, Elizabeth
    Sista, Nirupama
    Adeyeye, Adeola
    Rooney, James F.
    Rinehart, Alex
    Spreen, William R.
    Smith, Kimberly
    Hanscom, Brett
    Cohen, Myron S.
    Hosseinipour, Mina C.
    [J]. LANCET, 2022, 399 (10337) : 1779 - 1789